Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Related Articles by Review for PubMed (Select 23194815)

1.

Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia.

Calderone DJ, Martinez A, Zemon V, Hoptman MJ, Hu G, Watkins JE, Javitt DC, Butler PD.

Neuroimage. 2013 Feb 15;67:153-62. doi: 10.1016/j.neuroimage.2012.11.019. Epub 2012 Nov 27. Erratum in: Neuroimage. 2013 Dec;83:1110.

2.

Steady state responses: electrophysiological assessment of sensory function in schizophrenia.

Brenner CA, Krishnan GP, Vohs JL, Ahn WY, Hetrick WP, Morzorati SL, O'Donnell BF.

Schizophr Bull. 2009 Nov;35(6):1065-77. doi: 10.1093/schbul/sbp091. Epub 2009 Sep 2. Review.

3.

Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.

Green MF, Butler PD, Chen Y, Geyer MA, Silverstein S, Wynn JK, Yoon JH, Zemon V.

Schizophr Bull. 2009 Jan;35(1):163-81. doi: 10.1093/schbul/sbn156. Epub 2008 Nov 20. Review.

4.

Perceptual measurement in schizophrenia: promising electrophysiology and neuroimaging paradigms from CNTRICS.

Butler PD, Chen Y, Ford JM, Geyer MA, Silverstein SM, Green MF.

Schizophr Bull. 2012 Jan;38(1):81-91. doi: 10.1093/schbul/sbr106. Epub 2011 Sep 2.

5.

Neural bases of visual deficits during aging.

Spear PD.

Vision Res. 1993 Dec;33(18):2589-609. Review.

PMID:
8296455
6.

Contrast sensitivity and magnocellular functioning in schizophrenia.

Skottun BC, Skoyles JR.

Vision Res. 2007 Oct;47(23):2923-33. Epub 2007 Sep 6. Review.

7.

Stereopsis and magnocellular sensitivity in schizophrenia.

Skottun BC, Skoyles JR.

World J Biol Psychiatry. 2009;10(4 Pt 3):697-701. doi: 10.1080/15622970701849945. Review.

PMID:
18609415
8.

Neuropsychiatric aspects of schizophrenia.

Gur RE.

CNS Neurosci Ther. 2011 Feb;17(1):45-51. doi: 10.1111/j.1755-5949.2010.00220.x. Epub 2011 Jan 2. Review.

PMID:
21199445
9.

Steady-state visually evoked potentials: focus on essential paradigms and future perspectives.

Vialatte FB, Maurice M, Dauwels J, Cichocki A.

Prog Neurobiol. 2010 Apr;90(4):418-38. doi: 10.1016/j.pneurobio.2009.11.005. Epub 2009 Dec 4. Review.

PMID:
19963032
10.

Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders.

Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T.

Biol Psychiatry. 2011 Jul 1;70(1):7-12. doi: 10.1016/j.biopsych.2011.01.041. Epub 2011 May 6. Review.

11.

Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations.

Barch DM, Mathalon DH.

Biol Psychiatry. 2011 Jul 1;70(1):13-8. doi: 10.1016/j.biopsych.2011.01.004. Epub 2011 Feb 21. Review.

12.

Windows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophrenia.

Yoon JH, Sheremata SL, Rokem A, Silver MA.

Front Psychol. 2013 Oct 31;4:681. doi: 10.3389/fpsyg.2013.00681. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk